We had We had the opportunity to speak with one of the lead authors of this work, Dr. Jan Molenaar of the Princess Máxima Centre about its significance and what it means for patients.

We have started the year with a new addition to the research team, our Research and Digital Comms Officer Emily Hall who will be focused on sharing and celebrating our research work and helping families navigate the world of neuroblastoma research.

In honour of the International Day for Women and Girls in Science, we've been chatting to our Senior Trials Coordinator Dr Emma pond about her role and the fantastic work she does for SKC.

Every 2 years the Advances in Neuroblastoma Research conference invites researchers and clinicians worldwide who work in the field of neuroblastoma to come together and share their latest work.

In her latest blog our CEO, Gail Jackson reflects on entering a new year and what 2021 and beyond may bring for the charity.

Solving Kids’ Cancer is proud to stand beside Fiona Govan and the entire DIPG community, following their incredible advocacy work calling for increased funding for research into the most difficult-to-treat childhood cancers.

We are delighted to have announced the first International Neuroblastoma Research Initiative award to be funded under our AMRC-accredited research funding process, which will see a targeted drug introduced to frontline treatment for children with the hope

Grant awarded to Children’s Hospital of Philadelphia (CHOP) and Gustave Roussy in Paris to support Phase 3 clinical trial, representing the first-ever collaboration between these North American and European neuroblastoma consortia.

Our CEO, Gail, reflects on 'Pandemic Fatigue' and the importance of celebrating success in the face of challenge.